Greenberg Traurig Shareholders Roman Fayerberg and Cliff Merrell Presented at DeviceTalks: Minnesota
BOSTON (PRWEB) October 01, 2015 -- Roman Fayerberg and Cliff Merrell, shareholders at international law firm Greenberg Traurig LLP, were featured speakers at the 2015 DeviceTalks: Minnesota, Sept. 23, 2015, at the Science Museum of Minnesota.
On Wednesday, Sept, 23rd from 4 – 5:30 p.m., Fayerberg and Merrell presented, "Putting on Your Legal Cap – Hot Legal Topics That Can Influence Your Medtech Company?” Specifically, the panel discussed:
• What every medtech company needs to know about products liability litigation;
• M&A trends from the perspective of both acquirer and seller; and
• IP protection is key to a successful exit.
Fayerberg is a patent attorney and shareholder in Greenberg Traurig LLP's Intellectual Property (IP) Group in Boston. He focuses on the development and management of strategic patent portfolios and counseling clients on patent issues, primarily in technologies related to life sciences. Fayerberg also advises clients in connection with intellectual property due diligence investigations for venture capital investment, mergers and acquisitions, and licensing opportunities. His patent practice builds on seven years of experience he gained as a research and development engineer at C.R. Bard and Boston Scientific Corporation.
Merrell is a shareholder in the firm’s Litigation Group in Atlanta. He focuses his practice on products liability litigation, with an emphasis on pharmaceutical and medical device litigation. As national counsel for many pharmaceutical and medical device manufacturers, Merrell has a wide range of experience managing products liability litigation in state court, federal court, and multidistrict litigation (MDL). He has litigated cases involving a wide range of branded and generic pharmaceutical products for pain relief, depression, weight loss, birth control, and menopause. He has also litigated cases involving a wide range of medical devices, including insulin pumps, surgical mesh, endotracheal tubes, neurostimulators, and implantable cardioverter-defibrillators (ICDs).
About Greenberg Traurig’s Life Sciences & Medical Technology Group
Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice
The Pharmaceutical, Medical Device & Health Care Litigation Practice is an integral part of the firm’s 600-plus member national Litigation Practice. The team is nationally recognized for its dynamic courtroom presence, responsiveness to clients and deep subject matter knowledge. Recent recognitions include national rankings for 2015 “Products Liability & Mass Torts” from Chambers USA Guide; national rankings for 2015 “Product Liability & Mass Torts Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States; and a first-tier national ranking for "Litigation – Mass Tort Litigation and Class Actions – Defendants" from U.S. News – Best Lawyers® 2015 Best Law Firms. In addition, Greenberg Traurig is recognized as a "Product Liability Litigation Standout" in the BTI Litigation Outlook 2015 published by BTI Consulting Group.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 1900 attorneys serving clients from 38 offices in the United States, Latin America, Europe, Asia, and the Middle East. The firm is No 1. on the 2015 Law360 Most Charitable Firms list, third largest in the U.S. on the 2015 Law360 400, Top 20 on the 2015 Am Law Global 100, and among the 2015 BTI Brand Elite. More information at: http://www.gtlaw.com.
Lisa Murray, Greenberg Traurig, http://www.gtlaw.com, +1 617.835.0396, [email protected]
Share this article